06622.HK
Zhaoke Ophthalmology Limited
HKSE · Healthcare · Biotechnology · CN
HKD 2.53
+1.61%Year over year
Reported trailing growth
- Revenue
- +2.3%
- EBITDA
- +31.5%
- EBIT
- +20.1%
- EPS
- +31.8%
- Free cash flow
- +63.9%
- Operating cash flow
- +61.5%
Forward estimates
Based on analyst estimates
- Revenue
- -79.7%
- EBITDA
- -54.0%
- EPS
- -79.6%
Three-year CAGR
- Revenue
- +28.9%
- EBITDA
- +14.2%
- EBIT
- -16.9%
- Net income
- +14.3%
- EPS
- +14.0%
- Free cash flow
- +11.0%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026